Risk of outcomes in a Spanish population with chronic kidney disease

Objectives To assess mortality and cardiovascular and renal outcomes among patients with chronic kidney disease (CKD) (primary objective), with a particular focus on heart failure (HF) risk following diagnosis of CKD (secondary objective) in Spain. Methods We conducted an observational study comprising cross-sectional and longitudinal retrospective analyses using secondary data from electronic health records. For the primary objective, adults with prevalent CKD [estimated glomerular filtration rate (eGFR) <60 or >= 60 mL/min/1.73 m(2) with a urine albumin:creatinine ratio (UACR) >= 30 mg/g at the index date (1 January 2017)] were included. For the secondary objective, adults with incident CKD in 2017 were enrolled. Results In the prevalent population, 46 786 patients with CKD without HF [75.8 +/- 14.4 years, eGFR 51.4 +/- 10.1 mL/min/1.73 m(2); 75.1% on renin-angiotensin system inhibitors (RASis)] and 8391 with CKD and HF (79.4 +/- 10.9 years, eGFR 46.4 +/- 9.8 mL/min/1.73 m(2)) were included. In the prevalent population, the risk of all-cause death {hazard ratio [HR] 1.107 [95% confidence interval (CI) 1.064-1.153]}, HF hospitalization [HR 1.439 (95% CI 1.387-1.493)] and UACR progression [HR 1.323 (95% CI 1.182-1.481)] was greater in those patients with CKD and HF versus CKD only. For the incident population, 1594 patients with CKD without HF and 727 with CKD and HF were included. Within 24 months from the CKD diagnosis (with/without HF at baseline), 6.5% of patients developed their first HF hospitalization. Although 60.7% were taking RASis, only 3.4% were at maximal doses and among diabetics, 1.3% were taking sodium-glucose cotransporter-2 inhibitors. Conclusions The presence of HF among CKD patients markedly increases the risk of outcomes. CKD patients have a high risk of HF, which could be partially related to insufficient treatment.

Automated summary

This study found that the presence of heart failure (HF) in patients with chronic kidney disease (CKD) significantly increases the risk of adverse outcomes. It also observed a high risk of HF among CKD patients, which might be partially related to insufficient treatment.